C12N 2795/00022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2795/00022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 62 US grants and 122 published applications in this corpus.
Search patents in C12N- Granted patents
- 62
- Published applications
- 122
- Assignees
- 86
- Inventors
- 285
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 4 |
| 2012 | 3 | 3 |
| 2013 | 1 | 3 |
| 2014 | 4 | 6 |
| 2015 | 4 | 4 |
| 2016 | 6 | 7 |
| 2017 | 5 | 5 |
| 2018 | 3 | 3 |
| 2019 | 4 | 7 |
| 2020 | 2 | 6 |
| 2021 | 6 | 12 |
| 2022 | 4 | 15 |
| 2023 | 7 | 4 |
| 2024 | 7 | 14 |
| 2025 | 2 | 11 |
| 2026 | 2 | 10 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bacteriophages producing heterologous bacteriocins7 Jul 2026US 12,673,078 B2ETH Zurich
- Engineered MCP and PCP proteins and systems and methods thereof26 May 2026US 12,637,493 B2Trustees of Boston University
- Phage cocktail against E. coli 015723 Sep 2025US 12,419,328 B2Micreos Food Safety B.V.
- Lipid-free anchoring of thermophilic bacteriophage G20c portal adapter into solid-state nanopores3 Jun 2025US 12,320,796 B2Northeastern University
- Polypeptides and antibiotics against gram-negative bacterium comprising the same1 Oct 2024US 12,102,667 B2Hankuk University of Foreign Studies Research & Business Foundation
- Programmable miRNA-Dependent Gene Expression1 Oct 2026US 2026/0295089 A1New York University
- Prolactin Receptor Antibody and Use Thereof24 Sep 2026US 2026/0285993 A1
- Intracellular Delivery of Therapeutic Cargos and Viral RNAS by Engineered Salmonella17 Sep 2026US 2026/0272995 A1The Trustees of Columbia University in the City of New York
- Bacteriophage, salmonella bacteriolytic agent, composition, and method for controlling bacteria of the genus salmonella27 Aug 2026US 2026/0248139 A1Kaneka Corporation
- Bacteriophage, composition, and method for controlling bacteria of the genus salmonella27 Aug 2026US 2026/0248865 A1Kaneka Corporation
Most cited
By later US patents
- Evolution of proteases17US 10,920,208 B2President and Fellows of Harvard College · 2021
- A25 bacteriophage lysin6US 8,951,532 B2Alere Scarborough, Inc. · 2015
- Evolution of proteases4US 11,760,986 B2President and Fellows of Harvard College · 2023
- Phage therapy of E coli infections3US 10,918,680 B2Pherecydes Pharma · 2021
- Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles3US 11,208,437 B2Eligo Bioscience · 2021